Hebei Lansheng Biotech Co., Ltd.

UPL Q3 Results: Profit Meets Estimates As Latin American Markets Shineqrcode

Feb. 10, 2020

Favorites Print
Feb. 10, 2020
UPL Ltd.’s third-quarter profit met estimates on higher revenue growth in Latin American markets.

The agro-chemical maker reported a net profit of Rs 701 crore for the three months ended December, according to its exchange filing. That compares with Rs 693.5 crore that analysts surveyed by Bloomberg had forecast. The numbers are not comparable due to the firm’s acquisition of U.S.-based Arysta Lifescience Inc. last year.

Revenue stood at Rs 8,892 crore—analysts had pegged the top line at Rs 9,173 crore. The company, in its presentation, said the Latin American business grew 21 percent year-on-year to Rs 4,203 crore adjusted for Arysta acquisition.Brazil crop protection demand on soybeans benefitting from the U.S.-China trade war and higher export duties levied in Argentina were the factors aiding the performance in South America, the firm said. The domestic business, too, rose 41.5 percent year-on-year to Rs 750 crore.
Operating profit or earnings before interest, tax, depreciation and amortisation was at Rs 2,070 crore for the three-month period—the estimate was Rs 1,883 crore. The company’s operating margin stood at 23.3 percent—higher than the analysts’ forecast of 20.5 percent.
The Mumbai-based firm said that the tax authorities conducted search at multiple premises of the company last month. “We continue our engagement with the authorities and expect this process of review will continue for some time,” it said.
Source: Bloomberg

Picture 0/1200

More from AgroNews


2021 Certified Organic Agri-inputs Guide Chinese issue of Annual Review 2020
Annual Review 2020 2020 India Pesticide Suppliers Guide
2020 Market Insight Chinese issue of 2020 Market Insight
I wanna post a press Comment


Subscribe Email: *
Mobile Number:  


Picture 0/1200

Subscribe to daily email alerts of AgroNews.